In conclusion, they recommended performing LT for patients with HCC with the following features; AFP should be <200 ng/ml and the sum of the number and size of tumors (in centimeters) should not exceed 7; if the level of AFP 200–400 ng/ml, the sum of the number and size of tumors should be ≤5; if the level of AFP 400–1,000 ng/ml, the sum of the number and size of tumors should be ≤4. The gene discussed is AFP; the disease is hepatocellular carcinoma.